{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02600156",
            "orgStudyIdInfo": {
                "id": "14-005500"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors",
            "officialTitle": "A Pilot Study to Evaluate Magnetic Resonance Thermal Image-Guided Focal Laser Ablation of Prostate Cancer Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "focal-laser-ablation-of-low-to-intermediate-prostate-cancer-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2015-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2015-09-04",
            "studyFirstSubmitQcDate": "2015-11-05",
            "studyFirstPostDateStruct": {
                "date": "2015-11-09",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2023-12-22",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "David A. Woodrum",
                "investigatorTitle": "David A. Woodrum, M.D., Ph.D.",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.",
            "detailedDescription": "The study is being done to evaluate the safety and effectiveness of Magnetic Resonance Imaging (MRI)-guided focal laser therapy with the Visualase Thermal Therapy System to treat low-risk prostate cancer tumors. Unlike surgery or radiotherapy which affects a large portion of the prostate or the entire organ, localized or focal therapy is intended to treat a small portion of tissue in which the cancer has been found by biopsy."
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer",
                "Prostate Adenocarcinoma",
                "Stage I Prostate Cancer AJCC v8",
                "Stage II Prostate Cancer AJCC v8",
                "Localized Prostate Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single arm study",
                    "type": "EXPERIMENTAL",
                    "description": "MR guided focal laser ablation of prostate cancer using the Visualase Thermal Therapy System.",
                    "interventionNames": [
                        "Procedure: Focal laser ablation of the prostate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Focal laser ablation of the prostate",
                    "description": "MR guided laser ablation of the focal prostatic lesion which has been identified by MRI and biopsy prior to ablation.",
                    "armGroupLabels": [
                        "Single arm study"
                    ],
                    "otherNames": [
                        "Visualase Laser Ablation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Success rate",
                    "description": "To evaluate the procedural success rate of using the MR-guided laser ablation to target, access, thermally monitor, and focally ablate MR-visible prostate cancer lesions.",
                    "timeFrame": "3 years"
                },
                {
                    "measure": "Incidence of treatment emergent adverse events",
                    "description": "To evaluate patient-related safety by monitoring short and long-term complications related to the procedure such as but not limited to incontinence, impotence, and urethral fistulas.",
                    "timeFrame": "3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Short- and mid-term ablative success",
                    "description": "To obtain preliminary data on ablative success using longitudinal MR imaging assessment of treated areas.",
                    "timeFrame": "3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\n* Male, 45 years of age or older.\n* Diagnosis of prostate adenocarcinoma.\n* Clinical stage T1c or T2a.\n* Gleason score of 7 (3+4 or 4+3) or Intermediate risk Gleason 6\n* PSA less than or equal to 20 ng/mL\n* Three or fewer biopsy locations with prostate cancer which correlate with MRI findings.\n* No lesion \\> or = 2cm\n* One, two, or three tumor suspicious regions identified on multiparametric MRI\n* No definite radiographic indication of extra-capsular extension.\n* Estimated survival of 5 years or greater, as determined by treating physician.\n* Tolerance for anesthesia/sedation.\n* Ability to give informed consent.\n\nExclusion Criteria\n\n* Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.\n* History of other primary non-skin malignancy within previous three years.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "45 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Deb Berg",
                    "role": "CONTACT",
                    "phone": "507-255-8454",
                    "email": "rstinterventionaloncology@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Woodrum, MD, PhD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Minnesota",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deb Berg",
                            "role": "CONTACT",
                            "phone": "507-255-8454",
                            "email": "rstinterventionaloncology@mayo.edu"
                        },
                        {
                            "name": "David A. Woodrum, M.D., Ph.D",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        }
    },
    "hasResults": false
}